Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Frontiers in Endocrinology|February 25, 2021
Neonatal Suckling, Oxytocin, and Early Infant Attachment to the MotherRaymond Nowak, Frédéric Lévy, Elodie Chaillou, et al.
European Journal of Pharmacology|August 15, 2002
A nonpeptide oxytocin receptor antagonist radioligand highly selective for human receptorsWei Lemaire, Julie A O'Brien, Maryann Burno, et al.
Bioorganic & Medicinal Chemistry Letters|March 1, 2006
Tetrazole thioacetanilides: potent non-nucleoside inhibitors of WT HIV reverse transcriptase and its K103N mutantEster Muraglia, Olaf D Kinzel, Ralph Laufer, et al.
Bioorganic & Medicinal Chemistry Letters|December 15, 2007
Design and synthesis of substituted 4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazine-2-carboxamides, novel HIV-1 integrase inhibitorsH Marie Langford, Peter D Williams, Carl F Homnick, et al.
Protein Expression and Purification|January 12, 2010
Purification of untagged HIV-1 reverse transcriptase by affinity chromatographyMeiqing Lu, Winnie Ngo, Ye Mei, et al.
Bioorganic & Medicinal Chemistry Letters|November 8, 2016
Discovery of highly potent and selective orexin 1 receptor antagonists (1-SORAs) suitable for in vivo interrogation of orexin 1 receptor pharmacologyCraig A Stump, Andrew J Cooke, Joseph Bruno, et al.
Bioorganic & Medicinal Chemistry Letters|September 3, 2005
Development of an oxazolopyridine series of dual thrombin/factor Xa inhibitors via structure-guided lead optimizationJames Z Deng, Daniel R McMasters, Philippe M A Rabbat, et al.
Journal of Virology|May 21, 2010
Structural basis for the inhibition of RNase H activity of HIV-1 reverse transcriptase by RNase H active site-directed inhibitorsHua-Poo Su, Youwei Yan, G Sridhar Prasad, et al.
Bioorganic & Medicinal Chemistry Letters|July 21, 2004
Low molecular weight thrombin inhibitors with excellent potency, metabolic stability, and oral bioavailabilityMatthew M Morrissette, Kenneth J Stauffer, Peter D Williams, et al.
Bioorganic & Medicinal Chemistry Letters|February 8, 2011
Design, synthesis and SAR of a series of 1,3,5-trisubstituted benzenes as thrombin inhibitorsRichard C A Isaacs, Christina L Newton, Kellie J Cutrona, et al.
Pageof 2